{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:57:44Z","timestamp":1791385064098,"version":"4.3.3"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0228212","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T21:06:54Z","timestamp":1580245614000},"page":"e0228212","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7422-3878","authenticated-orcid":true,"given":"Mitsuharu","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunobu","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Nambu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M.","family":"Erion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"issue":"Suppl 1","key":"pone.0228212.ref001","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"S. Bellentani","year":"2017","journal-title":"Liver Int"},{"issue":"1","key":"pone.0228212.ref002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"pone.0228212.ref003","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"H Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"pone.0228212.ref004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37","author":"P. Bedossa","year":"2017","journal-title":"Liver Int"},{"issue":"12","key":"pone.0228212.ref005","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"DL White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"pone.0228212.ref006","doi-asserted-by":"crossref","first-page":"643e1","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired biopsy studies","volume":"13","author":"S Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"18","key":"pone.0228212.ref007","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"AJ Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0228212.ref008","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-Term Pioglitazone Treatment for Patients with Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial","volume":"165","author":"K Cusi","year":"2016","journal-title":"Ann Intern Med"},{"issue":"7","key":"pone.0228212.ref009","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"N Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0228212.ref010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/bcp.12899","article-title":"The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease","volume":"83","author":"M Del Ben","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"pone.0228212.ref011","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"JD Browning","year":"2004","journal-title":"J Clin Invest"},{"issue":"16","key":"pone.0228212.ref012","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00018-005-5121-4","article-title":"Acetyl-coenzyme A carboxylase: Crucial metabolic enzyme and attractive target for drug discovery","volume":"62","author":"L Tong","year":"2005","journal-title":"Cell Mol Life Sci"},{"issue":"31","key":"pone.0228212.ref013","doi-asserted-by":"crossref","first-page":"28410","DOI":"10.1074\/jbc.M300553200","article-title":"Acetyl-CoA carboxylase beta gene is regulated by sterol regulatory element-binding protein-1 in liver","volume":"278","author":"SY Oh","year":"2003","journal-title":"J Biol Chem"},{"issue":"Pt2","key":"pone.0228212.ref014","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/BST0340223","article-title":"Regulation of acetyl-CoA carboxylase","volume":"34","author":"RW Brownsey","year":"2006","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"pone.0228212.ref015","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1073\/pnas.97.4.1444","article-title":"The subcellular localization of acetyl-CoA carboxylase 2","volume":"97","author":"L Abu-Elheiga","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt3","key":"pone.0228212.ref016","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1042\/bj3160915","article-title":"Identification of a second human acetyl-CoA carboxylase gene","volume":"316","author":"J Widmer","year":"1996","journal-title":"Biochem J"},{"issue":"3","key":"pone.0228212.ref017","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0021-9258(19)40045-8","article-title":"Identification of an isozymic form of acetyl-CoA carboxylase","volume":"265","author":"A Bianchi","year":"1990","journal-title":"J Biol Chem"},{"issue":"5","key":"pone.0228212.ref018","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"KL Donnelly","year":"2005","journal-title":"J Clin Invest"},{"issue":"3","key":"pone.0228212.ref019","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"JE Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"pone.0228212.ref020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation","volume":"26","author":"CW Kim","year":"2017","journal-title":"Cell Metab"},{"issue":"5","key":"pone.0228212.ref021","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/MCB.01122-06","article-title":"Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice","volume":"27","author":"N Harada","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"22","key":"pone.0228212.ref022","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1073\/pnas.0603115103","article-title":"Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis","volume":"103","author":"J Mao","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"pone.0228212.ref023","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.1073\/pnas.1733877100","article-title":"Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat\/high-carbohydrate diets","volume":"100","author":"L Abu-Elheiga","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"pone.0228212.ref024","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI27300","article-title":"Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2","volume":"116","author":"DB Savage","year":"2006","journal-title":"J Clin Invest"},{"issue":"13","key":"pone.0228212.ref025","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","article-title":"Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats","volume":"113","author":"G Harriman","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl. 1734","key":"pone.0228212.ref026","article-title":"Evaluation of Cytochrome P450- and Transporter-Mediated Drug-Drug Interactions with the Acetyl-CoA Carboxylase Inhibitor GS-0976 and Phenotypic Probe Substrates and Inhibitors","volume":"68","author":"Elijah Weber","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"pone.0228212.ref027","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1053\/j.gastro.2018.07.027","article-title":"GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients with Nonalcoholic Fatty Liver Disease","volume":"155","author":"R Loomba","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0228212.ref028","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2005.08.035","article-title":"Divergence of melanocortin pathways in the control of food intake and energy expenditure","volume":"123","author":"N Balthasar","year":"2005","journal-title":"Cell"},{"issue":"12","key":"pone.0228212.ref029","doi-asserted-by":"crossref","first-page":"e82163","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"M Itoh","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"pone.0228212.ref030","doi-asserted-by":"crossref","first-page":"e0121528","DOI":"10.1371\/journal.pone.0121528","article-title":"Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice","volume":"10","author":"K Konuma","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"pone.0228212.ref031","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/hep.30097","article-title":"Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents","volume":"68","author":"L Goedeke","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"pone.0228212.ref032","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11248-012-9651-x","article-title":"Generation of gene-targeted mice using embryonic stem cells derived from a transgenic mouse model of Alzheimer\u2019s disease","volume":"22","author":"S Yamamoto","year":"2013","journal-title":"Transgenic Res"},{"issue":"6","key":"pone.0228212.ref033","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Nonalcoholic Steatohepatitis Clinical Research Network","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"pone.0228212.ref034","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","article-title":"Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease","volume":"29","author":"F Diraison","year":"2003","journal-title":"Diabetes Metab"},{"issue":"5","key":"pone.0228212.ref035","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"pone.0228212.ref036","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.cgh.2018.04.042","article-title":"Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients with Nonalcoholic Steatohepatitis","volume":"16","author":"EJ Lawitz","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"pone.0228212.ref037","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.redox.2015.08.015","article-title":"Redox-fibrosis: Impact of TGF\u03b21 on ROS generators, mediators and functional consequences","volume":"6","author":"K Richter","year":"2015","journal-title":"Redox Biol"},{"issue":"2","key":"pone.0228212.ref038","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Y Inagaki","year":"2007","journal-title":"Gut"},{"issue":"15","key":"pone.0228212.ref039","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1286-4579(99)00259-2","article-title":"TGF-beta: from latent to active","volume":"1","author":"N Khalil","year":"1999","journal-title":"Microbes Infect"},{"key":"pone.0228212.ref040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-4939-6786-5_19","article-title":"Optimized Mouse Models for Liver Fibrosis","volume":"1559","author":"YO Kim","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"12","key":"pone.0228212.ref041","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"S Satapati","year":"2015","journal-title":"J Clin Invest"},{"issue":"8","key":"pone.0228212.ref042","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"IA Leclercq","year":"2000","journal-title":"J Clin Invest"},{"issue":"34","key":"pone.0228212.ref043","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0505714102","article-title":"Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal","volume":"102","author":"L Abu-Elheiga","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"pone.0228212.ref044","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1073\/pnas.0913492107","article-title":"Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake","volume":"107","author":"DP Olson","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"pone.0228212.ref045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-5793(79)80157-X","article-title":"Stimulation by acetate of gluconeogenesis in hepatocyte suspensions","volume":"98","author":"PD Whitton","year":"1979","journal-title":"FEBS Lett"},{"issue":"14","key":"pone.0228212.ref046","doi-asserted-by":"crossref","first-page":"11420","DOI":"10.1074\/jbc.M008782200","article-title":"Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate","volume":"276","author":"T Fujino","year":"2001","journal-title":"J Biol Chem"},{"issue":"8","key":"pone.0228212.ref047","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of Nonalcoholic Steatohepatitis","volume":"150","author":"MV Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"pone.0228212.ref048","first-page":"221","article-title":"Molecular pathways in non-alcoholic fatty liver disease","volume":"7","author":"A Berlanga","year":"2014","journal-title":"Clin Exp Gastroenterol"},{"issue":"1","key":"pone.0228212.ref049","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","article-title":"Targeted disruption of the melanocortin-4 receptor results in obesity in mice","volume":"88","author":"D Huszar","year":"1997","journal-title":"Cell"},{"issue":"5","key":"pone.0228212.ref050","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.ajpath.2011.07.014","article-title":"Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis","volume":"179","author":"M Itoh","year":"2011","journal-title":"Am J Pathol"},{"key":"pone.0228212.ref051","doi-asserted-by":"crossref","first-page":"12977","DOI":"10.1038\/ncomms12977","article-title":"Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity","volume":"7","author":"N Kubota","year":"2016","journal-title":"Nat Commun"},{"issue":"9","key":"pone.0228212.ref052","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s41366-018-0062-9","article-title":"Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers","volume":"42","author":"M Honma","year":"2018","journal-title":"Int J Obes"},{"issue":"1\u20132","key":"pone.0228212.ref053","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2006.02.028","article-title":"Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet","volume":"536","author":"T Nagasawa","year":"2006","journal-title":"Eur J Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T15:22:48Z","timestamp":1614180168000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228212"}},"subtitle":[],"editor":[{"given":"Nobuyuki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0228212","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]}}}